A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants

NCT03841630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3437943
DRUG: Placebo

Sponsor

Eli Lilly and Company